BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6363188)

  • 1. [Beta 2-microglobulin in lymphoproliferative disorders].
    Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
    G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-2 microglobulin and malignant lymphoma].
    Krc I; Fischerová E; Matousková I
    Vnitr Lek; 1983 Nov; 29(11):1089-94. PubMed ID: 6362186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum levels of beta 2-microglobulin in malignant hemopathies].
    López Fernández A; Cuesta B; Rocha E
    Sangre (Barc); 1985; 30(3):320-9. PubMed ID: 3898421
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
    Child JA; Kushwaha MR
    Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta 2 microglobulin in lymphoproliferative status].
    Schaimberg L; Ikeda F; Cordeiro M; Santos RA; Murakami S; Scheinberg MA
    Rev Paul Med; 1987; 105(3):183-4. PubMed ID: 3329760
    [No Abstract]   [Full Text] [Related]  

  • 9. [HL-A antigens and malignant hematological diseases].
    Jeannet M; Alberto P; Wyss M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1798-800. PubMed ID: 5291103
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
    Garewal H; Durie BG
    Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
    Meier EC; Grob PJ
    Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059
    [No Abstract]   [Full Text] [Related]  

  • 13. beta 2 microglobulin in lymphoproliferative disorder.
    Spati B; Cooper EH; Child JA
    Lancet; 1978 Oct; 2(8095):897-8. PubMed ID: 81446
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders].
    Kłoczko J; Zuch A; Bielawiec M; Buluk K
    Acta Haematol Pol; 1983; 14(1):13-9. PubMed ID: 6577768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of adenosine and adenosine triphosphatase phosphoric esters in systemic histiocytic sarcomatoses].
    Mandelli F; Fontana L; Papa G; De Laurenzi A
    Riv Emoter Immunoematol; 1967; 14(5):221-44. PubMed ID: 4244545
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of "virus-like" particles in the plasmas of 255 patients with leukemia and related diseases.
    Newell GR; Harris WW; Bowman KO; Boone CW; Anderson NG
    N Engl J Med; 1968 May; 278(22):1185-91. PubMed ID: 4172474
    [No Abstract]   [Full Text] [Related]  

  • 18. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytochemical and immunologic characteristics of lymphocytes in lymphoproliferative diseases].
    Soboleva TN; Lukina EA; Mokeeva RA; Zhuravlev VS
    Lab Delo; 1984; (9):515-20. PubMed ID: 6210398
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of beta-2 microglobulin in clinical medicine.
    Hoekman K; Van Nieuwkoop JA; Willemze R
    Neth J Med; 1985; 28(12):551-7. PubMed ID: 3911084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.